tirzepatide drops effective are oral Semaglutide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes Struggling with constant hunger? Fighting

Comparative analysis of many classifiers This section evaluates all competing classification methods, namely DT, SVM, RF, KNN, ANN, and the proposed model, using the HAM10000 dataset based on the hyperparameter optimization of classification models in Table 2

It was approved by the FDA in 2021 as a once-weekly GLP-1 receptor agonist indicated for adults with a body mass index (BMI) of 30 (obesity) or 27 (overweight) with at least one weight-related medical condition

However, the translation from research to clinical application has a long journey

Concluding Comments There is an intricate relationship between obesity especially visceral obesity, as indicated by waist circumference and hyperuricemia, which can exacerbate complications associated with obesity